...GlaxoSmithKline ...Bloomberg's Michael McKee from Philadelphia about the company's study of its Avandia diabetes drug. An analysis of a Glaxo patient trial found that Avandia users had twice as ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Jean-Pierre Garnier, chief executive officer of GlaxoSmithKline Plc, talks with Bloomberg's Ellen Braitman from Washington about the safety of the company's Avandia diabetes drug. Glaxo representatives and officials of the U.S. Food and Drug Administration will attend hearings today by the U.S. House Oversight Committee on the drug's safety. (Source: Bloomberg)
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to: